Pattern Recognition Methods in 1H MRS Monitoring In Vivo of Normal Appearing Cerebellar Tissue After Treatment of Posterior Fossa Tumors

被引:4
作者
Boguszewicz, Lukasz [1 ]
Blamek, Slawomir [2 ]
Sokol, Maria [3 ]
机构
[1] Marie Curie Sklodowska Mem Canc Ctr & Inst Oncol, Dept Med Phys, Wybrzeze Armii Krajowej 15, PL-44101 Gliwice, Poland
[2] Maria Skodowska Curie Mem Canc Ctr & Inst Oncol, Dept Radiotherapy, Gliwice 44101, Poland
[3] Maria Skodowska Curie Mem Canc Ctr & Inst Oncol, Dept Med Phys, Ctr Oncol, Gliwice 44101, Poland
来源
BRAIN EDEMA XIV | 2010年 / 106卷
关键词
Magnetic resonance spectroscopy; pattern recognition; brain tumor; treatment monitoring; MAGNETIC-RESONANCE-SPECTROSCOPY; BRAIN-TUMORS; POSTOPERATIVE RADIOTHERAPY; CHILDREN; SPECTRA; CLASSIFICATION; NEUROBLASTOMA; CHEMOTHERAPY; GLIOMAS;
D O I
10.1007/978-3-211-98811-4_31
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The objective of this study was to investigate the metabolic responses of normal appearing cerebellar tissue after posterior fossa tumor treatment, and to identify characteristics of the particular treatment method. Moreover, this work examined the metabolic alterations of normal appearing tissue induced by a particular tumor state including resection, stagnation, progression, and recurrence. The studied group consisted of 29 patients treated for posterior fossa tumors. All of them were irradiated with a total dose of 54 Gy at 1.8 Gy/fraction (median values). In addition, 13 underwent: chemotherapy, 25 underwent total tumor resection, 18 were tumor-free in control examinations, 5 had a stable disease, and tumor progression or recurrence was observed in 2 and 4 cases, respectively. The 69 spectra, acquired using a MRI/MRS 2T system, were analyzed using; Partial Least Squares Discriminant Analysis (PLS-DA) with orthogonal signal correction (OSC) spectral filtering. A significantly elevated spectral region (0.97-1.55 ppm) was observed in patients after total resection in comparison to non-operated subjects. Patients treated with chemotherapy showed an elevated band between 1.15-1.75 and 2.7-3.0 ppm and had decreases in the remaining parts of the spectra. Increases in lactate and decreases in the remaining metabolites were characteristic for the tumor progression/recurrence group. Pattern recognition methods coupled with MRS revealed significant treatment-dependent alterations in normal appearing cerebellar tissue, as well as metabolic changes induced by tumor progression/recurrence.
引用
收藏
页码:171 / +
页数:3
相关论文
共 19 条
[1]   Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: Evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130) [J].
Beebe, DW ;
Ris, MD ;
Armstrong, FD ;
Fontanesi, J ;
Mulhern, R ;
Holmes, E ;
Wisoff, JH .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5198-5204
[2]   Neurological changes following radiation therapy for head and neck tumours [J].
Chong, VFH ;
Khoo, JBK ;
Chan, LL ;
Rumpel, H .
EUROPEAN JOURNAL OF RADIOLOGY, 2002, 44 (02) :120-129
[3]   White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia:: Longitudinal study with MR imaging and 1H MR spectroscopy [J].
Chu, WCW ;
Chik, KW ;
Chan, YL ;
Yeung, DKW ;
Roebuck, DJ ;
Howard, RG ;
Li, CK ;
Metreweli, C .
RADIOLOGY, 2003, 229 (03) :659-669
[4]   Classification of brain tumours using short echo time 1H MR spectra [J].
Devos, A ;
Lukas, L ;
Suykens, JAK ;
Vanhamme, L ;
Tate, AR ;
Howe, FA ;
Majós, C ;
Moreno-Torres, A ;
van der Graaf, M ;
Arús, C ;
Van Huffel, S .
JOURNAL OF MAGNETIC RESONANCE, 2004, 170 (01) :164-175
[5]   Cognitive sequelae in children with posterior fossa tumors [J].
George, AP ;
Kuehn, SM ;
Vassilyadi, M ;
Richards, PMP ;
Parlow, SE ;
Keene, DL ;
Ventureyra, ECG .
PEDIATRIC NEUROLOGY, 2003, 28 (01) :42-47
[6]   Magnetic resonance spectroscopy [J].
Gujar, SK ;
Maheshwari, S ;
Björkman-Burtscher, I ;
Sundgren, PC .
JOURNAL OF NEURO-OPHTHALMOLOGY, 2005, 25 (03) :217-226
[7]  
Li XJ, 2005, AM J NEURORADIOL, V26, P760
[8]   Proton magnetic resonance spectroscopy in neuroblastoma:: Current status, prospects and limitations [J].
Lindskog, M ;
Spenger, C ;
Klason, T ;
Jarvet, J ;
Gräslund, A ;
Johnsen, JI ;
Ponthan, F ;
Douglas, L ;
Nordell, B ;
Kogner, P .
CANCER LETTERS, 2005, 228 (1-2) :247-255
[9]   Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma [J].
Lindskog, M ;
Spenger, C ;
Jarvet, J ;
Gräslund, A ;
Kogner, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (19) :1457-1466
[10]  
Matulewicz L, 2006, FOLIA NEUROPATHOL, V44, P116